Delivery Order SPE2D018D0005-SPE2D021F0030
Award Date 10/23/20
Potential Completion Date 4/16/21
Potential Value $56K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order contract by the Defense Medical Supply Chain with a ceiling value of $1,767.32 for Rght Anti-A B Bcln 10ml Btl Orth Bb—a specialized blood bank diagnostic reagent. The contract award is dated July 18, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the company's facility in Raritan, New Jersey. This delivery order employs fixed-price contracting with economic price adjustment and was awarded...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- The U.S. Defense Health Agency awarded a $165,305.29 delivery order to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, for the provision of laboratory supplies. The contract has a completion date of September 30, 2021 and is a firm fixed price agreement. Ortho-Clinical Diagnostics Inc. provides a wide range of diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry systems, to various federal healthcare programs. The company has prior...
- The U.S. Defense Department's Medical Supply Chain awarded a $180,000 fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. for an Ortho Vision Analyzer on August 8, 2025, with an ultimate completion date of October 14, 2025. The contract carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey, specializes in providing advanced diagnostic solutions to federal healthcare...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $1,335.20 to Ortho-Clinical Diagnostics, Inc. on May 30, 2025, for ortho-clinical diagnostic solutions and enhanced orthopedic supplies. This firm fixed-price delivery order, which is due for completion by June 4, 2025, was awarded without set-aside designation, indicating open competition. The contract will be performed at the awardee's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc. is a...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $5,532.10 by the Defense Health Agency's Medical Supply Chain on September 26, 2025, for a RGT Anti-D BCLN 150ML MNCLN ABO GRP BB product. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of October 1, 2025, and will be performed in Raritan, New Jersey. The award was made without a set-aside designation, indicating open competition among...
- Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,910.02 on August 6, 2025, for Anti-A Bioclone 15x10ml medical diagnostic reagents. The contract, which will be completed by August 27, 2025, was issued without a set-aside designation, indicating open competition. The funding originates from the Medical Supply Chain within the Department of Defense, with the place of performance located in Raritan, New Jersey. This delivery order...
- The U.S. Department of Defense's Medical Supply Chain agency awarded Ortho-Clinical Diagnostics, Inc. a $2,298.68 fixed-price with economic price adjustment delivery order contract for the supply of medical control reagents. The contract has a performance period ending on November 29, 2024. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including products and services to federal agencies such as the Department of Veterans Affairs,...